Because innovation is everything

Our International Life Sciences & Healthcare group works with over 50% of the world’s largest pharmaceutical, biotechnology and medical devices companies. We have the largest patent litigation group in Europe and are recognised by major global directories as a top tier life sciences firm.

With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.

Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 270 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.

We can advise you on:

  • Technology transfers and IP Licensing
  • R&D collaborations
  • Patent and trade mark disputes and IP strategy
  • Clinical trials 
  • Privacy and data protection 
  • Regulatory and data exclusivity
  • Corporate transactions (including fundraising, IPOs and M&A)
  • Competition law 
  • e-health, m-health and digitalisation
  • Marketing arrangements and advertising
  • Pricing and reimbursement
  • Public procurement
  • Product liability
  • Employment

If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.


Show More Show Less


By the Life Sciences & Healthcare Group at Bird & Bird

Read more here

Discover the world of telemedicine

An international overview of the regulatory legislation

Download pdf

M-health & Medical Apps

The Key Legal Issues

Navigating the Legal Aspects of Mobile Health

Case studies

More Case Studies

Latest insights

More Insights
DNA blocks

Legal Win for NanoString and Bruker in patent battle

May 09 2024

Read More
Curiosity line green background

Frontline Asia-Pacific Employment Law Update: China

Apr 30 2024

Read More
colourful woven basket

Our take on some recent decisions of note from the UPC Court of Appeal

Apr 29 2024

Read More

Upcoming events

More Events
Results 1-5 of 5


Bird & Bird maintains an excellent reputation for its global life sciences work. The law firm's international platform is particularly strong in the UK, continental Europe and Asia.

Chambers Global, 2023

Insightful regulatory advice based on in-depth industry knowledge and the highest standard of legal expertise.

Legal 500, 2023

Bird & Bird has one of the finest IP and patent litigation practices in the world, routinely coordinating complex cross-border disputes.

Chambers UK, 2023

With 'unparalleled depth of industry knowledge’ and a ‘dynamic team', Bird & Bird LLP is ‘always focused on the client’s needs and strives to deliver solution-oriented, valuable advice'.

Legal 500, 2023

They have been very proactive and have perfectly met our proposed timelines. They are able to leverage their resources and knowledge.

Chambers Asia-Pacific, 2023

The quality of their advice is outstanding," says one client, adding: "It gives me a lot of comfort that I get direct contact with the team handling the matters.

Chambers Europe, 2022

Bird & Bird has more lawyers recommended for Life Sciences Patent Litigation across EMEA and Asia-Pacific than any other law firm in the 2023 edition of Who's Who Legal: Life Sciences Patent Litigation.

Practitioners Guide to the UPC 1st Edition

Helping you navigate the practice and procedure of the Unified Patent Court and Unitary Patent.

View and download the book

LMG Life Sciences Awards EMEA 2022

LMG Life Sciences Awards EMEA 2022
Two Impact Case of the Year Awards
- CE - 450163 Doctolib successful before Conseil d'État
- Pharmaceutical Works Polpharma SA v European Medicines Agency (EMA).

Read more here

LMG Life Sciences Awards EMEA 2023

Winner of Six Awards:
• EMEA M&A Firm of the Year
• EMEA Patent Litigation Firm of the Year: Medical Devices
• EMEA Venture Capital Firm of the Year
• Netherlands Firm of the Year
• Impact Case of the Year: Fingolimod
• Impact Deal of the Year: Dr Reddy’s Laboratories acquisition of Nimbus Health

Click here

News & Deals

More News & Deals


Bird & Bird ATMD advised lead investor Hatch Blue in agritech startup Peptobiotics' US$6.2 million Series A funding

Apr 15 2024

Read More


Bird & Bird succeeded in first substantive patent litigation appeal case at UPC Court of Appeal for NanoString

Feb 27 2024

Read More


Bird & Bird continues growth in intellectual property practice

Feb 05 2024

Read More


Bird & Bird advises Genetic Signatures Limited on its successful placement and rights issue raising AUD$16 million

Feb 02 2024

Read More


Bird & Bird appoints venture capital and private equity expert Félicien Bardsley as partner in Paris

Jan 16 2024

Read More


Bird & Bird grows intellectual property practice with arrival of life sciences patent litigator

Dec 18 2023

Read More

Relevant Downloads

ICLG Digital Health 2024
May 10 2024
Animal Health Regulation – An International Overview of Legislation
Jun 19 2023
Life Sciences & Healthcare - intro to our services
Mar 01 2024
The Legal 500: Pharmaceutical Advertising Comparative Guide 2023 - UK Chapter
Mar 01 2024

What's on TwoBirds TV?

More Videos